pl

Zarejestruj się
Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów.

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

Strona główna・Stock List・Zentalis Pharmaceuticals Inc
Search

Zentalis Pharmaceuticals Inc

Open

3.75 13.29

Buy

Price update 4 lis 2024, 20:57 UTC

BuySell

Overview

Share price change

24h

Current

Min

3.17

Max

4.06

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+246.39 upside

Dividends

By Dow Jones

Next Earnings

4 lis 2024

Technical Score

By Trading Central

Confidence

Very Strong Bullish Evidence

2.833 / 3.39 Support & Resistance

Zentalis Pharmaceuticals Inc Chart

Past performance is not a reliable indicator of future results.

Related News

16 wrz 2024, 11:52 UTC

Major Market Movers

Zentalis Shares Rise After U.S. FDA Lifts Hold on Azenosertib Studies

DJ

Read

18 cze 2024, 11:59 UTC

Major Market Movers

Zentalis Pharmaceuticals Shares Slide on Partial Clinical Holds on Cancer Drug Studies

DJ

Read

Peer Comparison

Price change

Zentalis Pharmaceuticals Inc Forecast

Price Target

By TipRanks

246.39% upside

12 Months Forecast

Average 11.5 USD  246.39%

High 20 USD

Low 4 USD

Based on 8 Wall Street analysts offering 12 month price targets forZentalis Pharmaceuticals Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

8 ratings

4

Buy

4

Hold

0

Sell

Based on 8 analysts giving stock ratings to Zentalis Pharmaceuticals Inc - Dist in the past 3 months.

Technical Score

By Trading Central

2.833 / 3.39Support & Resistance

Short Term

Very Strong Bullish Evidence

Recent bullish events outweigh bearish events.

Intermediate Term

Bullish Evidence

All events are bullish.

Long Term

Weak Bearish Evidence

There is one bearish event.

Financials

$

Other stocks from the sector

LLY

Eli Lilly and Co.

805.71

↓-1.45%

UNH

UnitedHealth Group Inc

556.95

↓-1.68%

JNJ

Johnson and Johnson

158.12

↓-1.16%

NVO

Novo Nordisk A-S

109.92

↓-1.81%

ABBV

AbbVie Inc

200.71

↓-1.24%